A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages

  Faggiano, Antongiulio ^a   Milone, F ^c   Ramundo, V ^c   Chiofalo, M G ^d   Ventre, I ^e   Giannattasio, R ^b   Severino, R ^c   Lombardi, G ^c   Colao, A ^c   Pezzullo, L ^d  

^a IRCCS SDN   (Italy)

^b Azienda Sanitaria Locale Napoli 1 Centro   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e G RUMMO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN; BIOLOGICAL MARKER;

ADULT; AGED; ANESTHESIA; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER REGRESSION; CANCER SURGERY; CELL HYPERPLASIA; CERVICAL LYMPH NODE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TREATMENT OUTCOME; BLOOD; CARCINOMA, MEDULLARY; CLINICAL TRIAL; DOWN REGULATION; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; OSMOLARITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REHABILITATION; REPRODUCIBILITY; THYROID NEOPLASMS; TIME;

ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; CARCINOMA, MEDULLARY; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM, RESIDUAL; OSMOLAR CONCENTRATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS;

EID: 77956597029     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0045     Document Type: Article

References (16)

1. Leboulleux S, Baudin E, Travagli JP, Schlumberger M 2004 Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61:299-310
2. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells Jr SA 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
3. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID 1992 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67:934-940
4. Dralle H, Machens A 2008 Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab 22:971-987
5. Machens A, Hauptmann S, Dralle H 2008 Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95:586-591
6. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E, Geerlings H, Pichlmayr R 1994 Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112-121
7. Moley JF, DeBenedetti MK 1999 Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880-887; discussion 887-888
8. Machens A, Hinze R, Thomusch O, Dralle H 2002 Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22-28
9. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075
10. Machens A, Hauptmann S, Dralle H 2007 Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960-1965
11. Scheuba C, Bieglmayer C, Asari R, Kaczirek K, Izay B, Kaserer K, Niederle B 2007 The value of intraoperative pentagastrin testing in medullary thyroid cancer. Surgery 141:166 -171; discussion 171-172
12. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455
13. Rago T, Vitti P, Chiovato L, Mazzeo S, De Liperi A, Miccoli P, Viacava P, Bogazzi F, Martino E, Pinchera A 1998 Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol 138:41-46
14. Wells Jr SA, Baylin SB, Leight GS, Dale JK, Dilley WG, Farndon JR 1982 The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg 195:595-599
15. Inabnet WB 2004 Intraoperative parathyroid hormone monitoring. World J Surg 28:1212-1215
16. Grauer A, Raue F, Ziegler R 1998 Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes 106:353-359